David R.W. Jayne - May 21, 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ David R.W. Jayne, M.D.
Stock symbol
AUPH
Transactions as of
May 21, 2024
Transactions value $
-$28,390
Form type
4
Date filed
5/22/2024, 04:11 PM
Previous filing
May 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale -$28.4K -4.95K -10.03% $5.74 44.4K May 21, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023.